Syndros can be used to treat anorexia due to AIDS, and nausea and vomiting due to chemotherapy.
Specialty Pharmacy
Advertisement
Treating modifiable risk factors could enhance breast cancer prevention.
Advertisement
Top articles of the week from The American Journal of Pharmacy Benefits.
Obstructive sleep apnea in MS patients can lead to deeper problems.
Anti-nausea and vomit medication could help reduce hospitalization in liver cancer.
Physicians caring for Medicaid patients will no longer receive payment bumps.
Advertisement
Antiretroviral therapy may alleviate some cognitive problems among HIV-positive patients.
Recent advances and updates in oncology and cancer drug development.
A more hands-on approach to patient care can improve overall outcomes.
MEDI4736 is an experimental human monoclonal antibody used against PDL1.
Advertisement
Adherence to a plant-based diet low in animal foods found to improve overall health.
Top news of the day from across the health care landscape.
Body mass index and smoking could have significant impact on RA remission.
Breast cancer cells found to hide in bone marrow before resurging.
Pancreatic cancer patients whose tumors surround critical blood vessels may have new treatment options.
Top articles of the week on Specialty Pharmacy Times.
Threat of legal action prompts several states to allow greater access to curative HCV drugs.
List prices for Complera and Stribild continue to rise for HIV treatment.
Too little or too much sleep can lead to inflammatory illnesses.
Immunotherapy for lung cancer patients may cause other conditions to become worse.
Top news of the day from across the health care landscape.
Daniel P. Kus, BS Pharm, RPh, vice president of Pharmacy Advantage, discusses the cost implications of pricey cholesterol-lowering PCSK9 inhibitors.
Top news of the day from across the healthcare landscape.
Vitamin A combined with Gemzar found to reduce proliferation of cancer cells.
Researchers still urge physicians to use caution utilizing light phototherapy for jaundice infants.
Off-label rilpivirine in combination with emtricitabine and tenofovir may help reduce out-of-pocket spending for patients with HIV.
Xilonix is the first monoclonal antibody immunotherapy that targets and neutralizes interleukin-1 alpha.
Long-term effects found among patients with diabetes who survive heart attacks.
Transplanting human stem cells into the spinal cord of patients with amyotrophic lateral sclerosis (ALS) shows promise.
Malignant brain tumor cells found to rely on fats for energy and growth.
Advertisement
Advertisement
